16 February

Synch Tech Series – Gene Editing

The Synch Tech Series is a forum where various new technologies are explained, analysed and discussed from technology, business and legal perspectives.

During the last years the field of genome engineering has taken huge steps forward. Along with the progress, many questions have arisen regarding technical development and business possibilities as well as legality and ethical issues. What is possible with genome engineering today? What opportunities lie around the corner or on the horizon? What is legally possible now and in the future? These questions will be discussed when some of the most experienced people within gene editing meet at Synch on 16 February 2016.

Roger Chang is a researcher at KI specializing in cancer and RNA and is the chairman of the RNA society in Stockholm. At the event Roger will give you an insight into the possibilities of modern gene editing techniques and the related costs.

Ryan Bethencourt, from the start-up accelerator Indie Bio in San Francisco, is a scientist, entrepreneur and biohacker who for the last decade has worked in the biopharmaceutical industry to partner on and develop novel drugs. He has had numerous publications in magazines such as Wired, Forbes and TechCrunch and will talk about the business opportunities related to this new technology.

Bo Ekstrand, from Bio Consult AB, has been responsible for a national GMO-network in Sweden since the mid-nineties, focussing on legal and ethical questions regarding genome editing, primarily in the food industry. Bo will give an overview of what is legal today and what is happening (or not happening) within the EU and other parts of the world.

Marie Nyman is the Administrative Director of Gentekniknämnden (the Swedish Gene Technology Advisory Board). Marie has extensive knowledge within the field and will participate in the event and join the following Q&A panel.

The event will be moderated by Hannes Sjöblad. Hannes is an entrepreneur, Singularity University Ambassador and a co-founder of the Swedish biohackers association BioNyfiken. He is passionate about the synthetic biology business and its World changing potential.

Agenda
17.00 Doors open
17.30 Presentations and Q&A panel
19.00 Networking
21.00 Doors close

Take the opportunity to learn more about gene editing, ask questions to experts within the field and network with the Synch community! Sign up here or send an e-mail to event@synchlaw.se

News and Insights
Press release

Malin Verga will head Synch’s operations in California’s innovation hub

June 20, 2017

Synch, one of the fastest growing law firms in Scandinavia, is the first Swedish agency to establish itself in the San Francisco area. Synch’s focus on digital business and technology is especially suitable for both large, established companies and new start-ups in and around Silicon Valley.

News

Synch the first Swedish law firm to establish business in San Francisco

June 20, 2017

Synch’s focus on digital business and technology is especially suitable for both large, established companies and new start-ups in and around Silicon Valley. 

Press release

SYNCH ACTED LEGAL ADVISOR TO THE SELLERS IN CONNECTION WITH EKSPRES BANK’S ACQUISITION OF SEVENDAY FINANS AB

June 14, 2017

SevenDay Finans is an independent credit market company based in Stockholm, specialising in unsecured lending to private consumers in Sweden.

Press release

Synch increases the presence in IAM Patent 1000 – The World’s Leading Patent Professionals 2017

June 7, 2017

The latest edition of IAM Patent 1000 has just been released and we are very proud to announce that both Sara Sparring and David Leffler are ranked as leading individuals in Sweden in the field of transactions. Synch is also recommended as leading firm within the same area.

Publications

Synch contributor to ICGL Product Liability Guide 2017

June 2, 2017

Synch’s Ida Häggström and Vencel Hodák provides an overview of Swedish law in the field of product liability.

Press release

SYNCH LEGAL ADVISOR TO ZOUK CAPITAL IN READLY’S SERIES B FINANCING ROUND OF EUR 13 MILLION

May 24, 2017

The investment was made to drive Readly’s next stage of development, to further its international expansion and support growth in its existing markets.